BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14743210)

  • 41. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.
    Dickson MA; Hahn WC; Ino Y; Ronfard V; Wu JY; Weinberg RA; Louis DN; Li FP; Rheinwald JG
    Mol Cell Biol; 2000 Feb; 20(4):1436-47. PubMed ID: 10648628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation.
    Milyavsky M; Tabach Y; Shats I; Erez N; Cohen Y; Tang X; Kalis M; Kogan I; Buganim Y; Goldfinger N; Ginsberg D; Harris CC; Domany E; Rotter V
    Cancer Res; 2005 Jun; 65(11):4530-43. PubMed ID: 15930270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic alterations in a telomerase-immortalized human esophageal epithelial cell line: implications for carcinogenesis.
    Cheung PY; Deng W; Man C; Tse WW; Srivastava G; Law S; Tsao SW; Cheung AL
    Cancer Lett; 2010 Jul; 293(1):41-51. PubMed ID: 20092939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells.
    Herbert BS; Wright WE; Shay JW
    Oncogene; 2002 Nov; 21(51):7897-900. PubMed ID: 12420227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retroviral-mediated expression of telomerase in normal human cells provides a selective growth advantage.
    Forsythe HL; Elmore LW; Jensen KO; Landon MR; Holt SE
    Int J Oncol; 2002 Jun; 20(6):1137-43. PubMed ID: 12011990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock.
    Munro J; Barr NI; Ireland H; Morrison V; Parkinson EK
    Exp Cell Res; 2004 May; 295(2):525-38. PubMed ID: 15093749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts.
    Kim H; You S; Kim IJ; Foster LK; Farris J; Ambady S; Ponce de León FA; Foster DN
    Oncogene; 2001 May; 20(21):2671-82. PubMed ID: 11420679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. hTERT antagonizes p53-induced apoptosis independently of telomerase activity.
    Rahman R; Latonen L; Wiman KG
    Oncogene; 2005 Feb; 24(8):1320-7. PubMed ID: 15608686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
    Zhou HW; Lou SQ; Zhang K
    Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his).
    Gollahon LS; Shay JW
    Oncogene; 1996 Feb; 12(4):715-25. PubMed ID: 8632893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression profiles of p53-, p16(INK4a)-, and telomere-regulating genes in replicative senescent primary human, mouse, and chicken fibroblast cells.
    Kim H; You S; Farris J; Kong BW; Christman SA; Foster LK; Foster DN
    Exp Cell Res; 2002 Jan; 272(2):199-208. PubMed ID: 11777345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
    DeInnocentes P; Agarwal P; Bird RC
    J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Telomerase-immortalized sheep fibroblasts can be reprogrammed by nuclear transfer to undergo early development.
    Cui W; Wylie D; Aslam S; Dinnyes A; King T; Wilmut I; Clark AJ
    Biol Reprod; 2003 Jul; 69(1):15-21. PubMed ID: 12606403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A methylation profile of in vitro immortalized human cell lines.
    Liu L; Zhang J; Bates S; Li JJ; Peehl DM; Rhim JS; Pfeifer GP
    Int J Oncol; 2005 Jan; 26(1):275-85. PubMed ID: 15586250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
    Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beryllium induces premature senescence in human fibroblasts.
    Coates SS; Lehnert BE; Sharma S; Kindell SM; Gary RK
    J Pharmacol Exp Ther; 2007 Jul; 322(1):70-9. PubMed ID: 17395767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).
    Chapman EJ; Williams SV; Platt FM; Hurst CD; Chambers P; Roberts P; Knowles MA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):694-710. PubMed ID: 19405089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.